Oaktop Capital Management Ii LP Has Increased Lam Research Com (LRCX) Stake by $544,000; Dolby Laboratories (DLB) Shareholder Price Michael F Has Decreased Holding

Lam Research Corporation (NASDAQ:LRCX) Logo

Price Michael F decreased its stake in Dolby Laboratories Inc. (DLB) by 1.57% based on its latest 2018Q4 regulatory filing with the SEC. Price Michael F sold 8,700 shares as the company’s stock declined 8.64% while stock markets rallied. The hedge fund held 546,155 shares of the multi-sector company at the end of 2018Q4, valued at $33.77 million, down from 554,855 at the end of the previous reported quarter. Price Michael F who had been investing in Dolby Laboratories Inc. for a number of months, seems to be less bullish one the $6.49 billion market cap company. The stock decreased 1.03% or $0.66 during the last trading session, reaching $63.24. About 64,808 shares traded. Dolby Laboratories, Inc. (NYSE:DLB) has declined 1.03% since April 2, 2018 and is downtrending. It has underperformed by 5.40% the S&P500. Some Historical DLB News: 25/04/2018 – Toshiba Launches Dolby Vision Capable TVs; 19/03/2018 – Dolby Laboratories and OPPO Form Strategic Intellectual Property Partnership; 13/03/2018 – Edgewater Networks and Dolby Announce the Certification of Dolby Conference Phones in Edgewater Networks’ QuickConnect Interoperability Lab; 18/04/2018 – DOLBY LABORATORIES INC DLB.N – SHOCHIKU MULTIPLEX THEATRES AND CO ENTERED INTO AN AGREEMENT FOR FIRST DEPLOYMENT OF DOLBY CINEM THEATRES IN JAPAN; 24/04/2018 – DOLBY LABS SEES 3Q ADJ EPS 78C TO 84C, EST. $1; 24/04/2018 – DOLBY LABORATORIES INC DLB.N FY2018 SHR VIEW $0.97, REV VIEW $1.18 BLN — THOMSON REUTERS l/B/E/S; 24/04/2018 – DOLBY LABS 2Q REV. $301.4M, EST. $300.3M; 19/03/2018 – DOLBY LABORATORIES INC DLB.N – FORMED A GLOBAL, STRATEGIC INTELLECTUAL PROPERTY PARTNERSHIP WITH GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP; 26/03/2018 – Dolby Labs Closes Above 50-Day Moving Average: Technicals; 23/03/2018 – OPPO and Dolby Laboratories Announce Global Strategic Intellectual Property Partnership

Oaktop Capital Management Ii Lp increased its stake in Lam Research Corp Com (LRCX) by 1.28% based on its latest 2018Q4 regulatory filing with the SEC. Oaktop Capital Management Ii Lp bought 4,000 shares as the company’s stock rose 15.56% with the market. The hedge fund held 316,504 shares of the industrial machinery and components company at the end of 2018Q4, valued at $43.10M, up from 312,504 at the end of the previous reported quarter. Oaktop Capital Management Ii Lp who had been investing in Lam Research Corp Com for a number of months, seems to be bullish on the $28.17 billion market cap company. The stock decreased 0.05% or $0.1 during the last trading session, reaching $184.6. About 483,904 shares traded. Lam Research Corporation (NASDAQ:LRCX) has declined 6.47% since April 2, 2018 and is downtrending. It has underperformed by 10.84% the S&P500. Some Historical LRCX News: 17/04/2018 – LAM RESEARCH CORP LRCX.O QUARTERLY NON-GAAP SHR $4.79; 17/04/2018 – LAM RESEARCH CORP LRCX.O QUARTERLY REVENUE $2.89 BLN; 06/03/2018 – LAM RESEARCH SAYS CY2021 TARGET MODEL REV. $14.5B-$15.5B; 06/03/2018 – LAM RESEARCH BOOSTS QTR DIV TO $1.10/SHARE FROM 50C, EST. 50C; 06/03/2018 Lam Research Corporation Announces Capital Return Program; 17/04/2018 – The analysis identified several other names with similarly optimistic analyst expectations, including Caterpillar and three chipmakers: Advanced Micro Devices, Lam Research and Cypress Semiconductor; 17/04/2018 – Lam Research Beats Revenue, EPS Expectations– Earnings Review; 17/04/2018 – Lam Research 3Q Net $778.8M; 17/04/2018 – LAM RESEARCH CORP SEES FOR JUNE 2018 QTR, U.S. GAAP SHIPMENTS $3.000 BLN +/- $150 MLN; 06/03/2018 – Lam Research: Capital Return Plan Includes Additional $2B Shr Repurchase Authorization

Analysts await Dolby Laboratories, Inc. (NYSE:DLB) to report earnings on April, 23. They expect $0.52 earnings per share, down 22.39% or $0.15 from last year’s $0.67 per share. DLB’s profit will be $53.36M for 30.40 P/E if the $0.52 EPS becomes a reality. After $0.58 actual earnings per share reported by Dolby Laboratories, Inc. for the previous quarter, Wall Street now forecasts -10.34% negative EPS growth.

More notable recent Dolby Laboratories, Inc. (NYSE:DLB) news were published by: Globenewswire.com which released: “Dolby Laboratories Reports Fourth Quarter and Fiscal 2018 Financial Results – GlobeNewswire” on October 24, 2018, also Seekingalpha.com with their article: “Stocks To Watch: Automakers, Macau Names And CinemaCon Action – Seeking Alpha” published on March 30, 2019, Globenewswire.com published: “Oscar Nominees Celebrate 91st Academy Awards with Dolby Laboratories – GlobeNewswire” on February 22, 2019. More interesting news about Dolby Laboratories, Inc. (NYSE:DLB) were released by: Seekingalpha.com and their article: “Dolby Laboratories: Still A Great Business And A Questionable Valuation – Seeking Alpha” published on November 28, 2018 as well as Globenewswire.com‘s news article titled: “Binge Smarter with Dolby Dimension NYSE:DLB – GlobeNewswire” with publication date: November 14, 2018.

Price Michael F, which manages about $734.16M US Long portfolio, upped its stake in Dowdupont Inc. by 125,000 shares to 355,640 shares, valued at $19.02 million in 2018Q4, according to the filing. It also increased its holding in Twenty (NASDAQ:FOX) by 35,000 shares in the quarter, for a total of 110,000 shares, and has risen its stake in Groupon Inc. (NASDAQ:GRPN).

Since November 1, 2018, it had 0 buys, and 13 selling transactions for $20.61 million activity. Shares for $254,800 were sold by GOTCHER PETER C on Tuesday, February 5. SHERMAN MARK ANDREW sold $305,063 worth of stock. CHEW LEWIS sold $2.21M worth of stock or 35,000 shares. 50,000 shares were sold by Dolby Dagmar, worth $3.26 million. JASPER N WILLIAM JR sold 3,920 shares worth $254,800. Baker Giles also sold $389,268 worth of Dolby Laboratories, Inc. (NYSE:DLB) on Monday, December 17.

Investors sentiment decreased to 0.96 in Q4 2018. Its down 0.72, from 1.68 in 2018Q3. It dived, as 35 investors sold DLB shares while 84 reduced holdings. 40 funds opened positions while 74 raised stakes. 55.35 million shares or 1.58% less from 56.24 million shares in 2018Q3 were reported. American Grp Inc Incorporated invested in 0% or 1,136 shares. Fuller Thaler Asset Mngmt Incorporated reported 904,170 shares stake. California-based California Pub Employees Retirement System has invested 0.01% in Dolby Laboratories, Inc. (NYSE:DLB). Captrust Financial Advisors accumulated 1,939 shares or 0.01% of the stock. Voya Inv Management Limited Company holds 13,075 shares or 0% of its portfolio. Parkside Bankshares & stated it has 0.01% of its portfolio in Dolby Laboratories, Inc. (NYSE:DLB). Great West Life Assurance Communications Can has 0% invested in Dolby Laboratories, Inc. (NYSE:DLB) for 7,704 shares. Pettee Invsts Inc invested in 14,925 shares. Moreover, Capital World Investors has 0.01% invested in Dolby Laboratories, Inc. (NYSE:DLB) for 800,000 shares. Ameriprise Fincl reported 0% of its portfolio in Dolby Laboratories, Inc. (NYSE:DLB). Metropolitan Life Ins New York reported 0% of its portfolio in Dolby Laboratories, Inc. (NYSE:DLB). Stone Ridge Asset Lc invested 0.18% in Dolby Laboratories, Inc. (NYSE:DLB). Lapides Asset Mngmt Limited Com stated it has 8,300 shares. Conestoga Cap Ltd Liability Co reported 6,293 shares. Hbk Invs LP accumulated 39,490 shares.

Since February 1, 2019, it had 0 buys, and 2 sales for $659,176 activity. Shares for $304,560 were sold by JENNINGS KEVIN.

Lam Research Corporation (NASDAQ:LRCX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.